×

We've got news for you.

Register on BusinessLIVE at no cost to receive newsletters, read exclusive articles & more.
Register now

Cancer screening has yet to recover to the levels seen before the coronavirus pandemic, heralding a future increase in late diagnosis with worse outcomes for patients, medical scheme administrator Momentum Health Solutions (MHS) warned on Monday.

The pandemic saw preventive screening for cancer plummet worldwide as healthcare facilities restricted access to care, and patients delayed non-urgent visits to GPs and specialists. Healthcare experts have warned since the outset of the pandemic that delaying tests used for early detection, particularly for cancers that are asymptomatic in their early stages, would see patients diagnosed at a more severe stage of their illness, with effects on their prognosis and treatment costs. Medical schemes are obliged by law to cover preventive screening tests for cancers of the breast, cervix, colon and prostate...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now

Would you like to comment on this article?
Register (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.

Commenting is subject to our house rules.